The vitamin D receptor agonist elocalcitol inhibits IL-8-dependent benign prostatic hyperplasia stromal cell proliferation and inflammatory response by targeting the RhoA/Rho kinase and NF-kB pathways

Giuseppe Penna, Benedetta Fibbi, Susana Amuchastegui, Elisa Corsiero, Gilles Laverny, Enrico Silvestrini, Aravinda Chavalmane, Annamaria Morelli, Erica Sarchielli, Gabriella Barbara Vannelli, Mauro Gacci, Enrico Colli, Mario Maggi, Luciano Adorini

Research output: Contribution to journalArticle

66 Citations (Scopus)

Abstract

BACKGROUND. Benign prostatic hyperplasia (BPH) is characterized by an important inflammatory component. Stimulation of human prostate stromal cells from BPH tissues with proinflammatory cytokines leads to secretion of IL-8, a chemokine involved in BPH pathogenesis. The vitamin D receptor (VDR) agonist elocalcitol can arrest prostate growth in BPH patients, but its mechanism of action in this pathology is still incompletely understood. METHODS. IL-8 levels were measured by real-time RT-PCR and ELISA. NF-κB translocation and COX-2 expression were evaluated by confocal microscopy. RhoA and Rho-kinase (ROCK) gene expression and functional activity were studied by real-time RT-PCR, immuno-kinase assays, Western blot analysis, confocal microscopy, and cell invasion. RESULTS. Stimulation of BPH cells with IL-8 activates the calcium-sensitizing RhoA/ROCK pathway, as demonstrated by the increased membrane translocation of RhoA and by phosphorylation of the ROCK substrate myosin phosphatase target subunit 1 (MYPT-1). In agreement with these data, C3 exoenzyme, a selective RhoA inhibitor, inhibits IL-8-induced invasion of BPH cells. The VDR agonist elocalcitol significantly inhibits IL-8 production by BPH cells stimulated with inflammatory cytokines, and IL-8-induced proliferation of BPH cells. In addition, elocalcitol inhibits IL-8-induced membrane translocation of RhoA and MYPT-1 phosphorylation in BPH cells, and inhibits dose-dependently their IL-8-dependent invasion. The inhibition induced by elocalcitol of IL-8 production by BPH cells is accompanied by decreased COX-2 expression and PGE2 production and by arrest of NF-κB p65 nuclear translocation, associated with inhibition of the RhoA/ROCK pathway. CONCLUSIONS. These data provide a mechanistic explanation for the anti-proliferative and anti-inflammatory properties of elocalcitol in BPH cells.

Original languageEnglish
Pages (from-to)480-493
Number of pages14
JournalProstate
Volume69
Issue number5
DOIs
Publication statusPublished - Apr 1 2009

Fingerprint

rho-Associated Kinases
Calcitriol Receptors
NF-kappa B
Prostatic Hyperplasia
Stromal Cells
Interleukin-8
Cell Proliferation
Myosin-Light-Chain Phosphatase
Confocal Microscopy
Real-Time Polymerase Chain Reaction
Prostate
BXL628
Phosphorylation
Cytokines
Membranes
Chemokines
Dinoprostone
Anti-Inflammatory Agents
Phosphotransferases
Western Blotting

Keywords

  • BPH cells
  • Elocalcitol
  • IL-8
  • VDR agonist

ASJC Scopus subject areas

  • Medicine(all)
  • Oncology
  • Urology

Cite this

The vitamin D receptor agonist elocalcitol inhibits IL-8-dependent benign prostatic hyperplasia stromal cell proliferation and inflammatory response by targeting the RhoA/Rho kinase and NF-kB pathways. / Penna, Giuseppe; Fibbi, Benedetta; Amuchastegui, Susana; Corsiero, Elisa; Laverny, Gilles; Silvestrini, Enrico; Chavalmane, Aravinda; Morelli, Annamaria; Sarchielli, Erica; Vannelli, Gabriella Barbara; Gacci, Mauro; Colli, Enrico; Maggi, Mario; Adorini, Luciano.

In: Prostate, Vol. 69, No. 5, 01.04.2009, p. 480-493.

Research output: Contribution to journalArticle

Penna, G, Fibbi, B, Amuchastegui, S, Corsiero, E, Laverny, G, Silvestrini, E, Chavalmane, A, Morelli, A, Sarchielli, E, Vannelli, GB, Gacci, M, Colli, E, Maggi, M & Adorini, L 2009, 'The vitamin D receptor agonist elocalcitol inhibits IL-8-dependent benign prostatic hyperplasia stromal cell proliferation and inflammatory response by targeting the RhoA/Rho kinase and NF-kB pathways', Prostate, vol. 69, no. 5, pp. 480-493. https://doi.org/10.1002/pros.20896
Penna, Giuseppe ; Fibbi, Benedetta ; Amuchastegui, Susana ; Corsiero, Elisa ; Laverny, Gilles ; Silvestrini, Enrico ; Chavalmane, Aravinda ; Morelli, Annamaria ; Sarchielli, Erica ; Vannelli, Gabriella Barbara ; Gacci, Mauro ; Colli, Enrico ; Maggi, Mario ; Adorini, Luciano. / The vitamin D receptor agonist elocalcitol inhibits IL-8-dependent benign prostatic hyperplasia stromal cell proliferation and inflammatory response by targeting the RhoA/Rho kinase and NF-kB pathways. In: Prostate. 2009 ; Vol. 69, No. 5. pp. 480-493.
@article{a9dbbc6d5a11482ba289f8106ae12a7c,
title = "The vitamin D receptor agonist elocalcitol inhibits IL-8-dependent benign prostatic hyperplasia stromal cell proliferation and inflammatory response by targeting the RhoA/Rho kinase and NF-kB pathways",
abstract = "BACKGROUND. Benign prostatic hyperplasia (BPH) is characterized by an important inflammatory component. Stimulation of human prostate stromal cells from BPH tissues with proinflammatory cytokines leads to secretion of IL-8, a chemokine involved in BPH pathogenesis. The vitamin D receptor (VDR) agonist elocalcitol can arrest prostate growth in BPH patients, but its mechanism of action in this pathology is still incompletely understood. METHODS. IL-8 levels were measured by real-time RT-PCR and ELISA. NF-κB translocation and COX-2 expression were evaluated by confocal microscopy. RhoA and Rho-kinase (ROCK) gene expression and functional activity were studied by real-time RT-PCR, immuno-kinase assays, Western blot analysis, confocal microscopy, and cell invasion. RESULTS. Stimulation of BPH cells with IL-8 activates the calcium-sensitizing RhoA/ROCK pathway, as demonstrated by the increased membrane translocation of RhoA and by phosphorylation of the ROCK substrate myosin phosphatase target subunit 1 (MYPT-1). In agreement with these data, C3 exoenzyme, a selective RhoA inhibitor, inhibits IL-8-induced invasion of BPH cells. The VDR agonist elocalcitol significantly inhibits IL-8 production by BPH cells stimulated with inflammatory cytokines, and IL-8-induced proliferation of BPH cells. In addition, elocalcitol inhibits IL-8-induced membrane translocation of RhoA and MYPT-1 phosphorylation in BPH cells, and inhibits dose-dependently their IL-8-dependent invasion. The inhibition induced by elocalcitol of IL-8 production by BPH cells is accompanied by decreased COX-2 expression and PGE2 production and by arrest of NF-κB p65 nuclear translocation, associated with inhibition of the RhoA/ROCK pathway. CONCLUSIONS. These data provide a mechanistic explanation for the anti-proliferative and anti-inflammatory properties of elocalcitol in BPH cells.",
keywords = "BPH cells, Elocalcitol, IL-8, VDR agonist",
author = "Giuseppe Penna and Benedetta Fibbi and Susana Amuchastegui and Elisa Corsiero and Gilles Laverny and Enrico Silvestrini and Aravinda Chavalmane and Annamaria Morelli and Erica Sarchielli and Vannelli, {Gabriella Barbara} and Mauro Gacci and Enrico Colli and Mario Maggi and Luciano Adorini",
year = "2009",
month = "4",
day = "1",
doi = "10.1002/pros.20896",
language = "English",
volume = "69",
pages = "480--493",
journal = "Prostate",
issn = "0270-4137",
publisher = "Wiley-Liss Inc.",
number = "5",

}

TY - JOUR

T1 - The vitamin D receptor agonist elocalcitol inhibits IL-8-dependent benign prostatic hyperplasia stromal cell proliferation and inflammatory response by targeting the RhoA/Rho kinase and NF-kB pathways

AU - Penna, Giuseppe

AU - Fibbi, Benedetta

AU - Amuchastegui, Susana

AU - Corsiero, Elisa

AU - Laverny, Gilles

AU - Silvestrini, Enrico

AU - Chavalmane, Aravinda

AU - Morelli, Annamaria

AU - Sarchielli, Erica

AU - Vannelli, Gabriella Barbara

AU - Gacci, Mauro

AU - Colli, Enrico

AU - Maggi, Mario

AU - Adorini, Luciano

PY - 2009/4/1

Y1 - 2009/4/1

N2 - BACKGROUND. Benign prostatic hyperplasia (BPH) is characterized by an important inflammatory component. Stimulation of human prostate stromal cells from BPH tissues with proinflammatory cytokines leads to secretion of IL-8, a chemokine involved in BPH pathogenesis. The vitamin D receptor (VDR) agonist elocalcitol can arrest prostate growth in BPH patients, but its mechanism of action in this pathology is still incompletely understood. METHODS. IL-8 levels were measured by real-time RT-PCR and ELISA. NF-κB translocation and COX-2 expression were evaluated by confocal microscopy. RhoA and Rho-kinase (ROCK) gene expression and functional activity were studied by real-time RT-PCR, immuno-kinase assays, Western blot analysis, confocal microscopy, and cell invasion. RESULTS. Stimulation of BPH cells with IL-8 activates the calcium-sensitizing RhoA/ROCK pathway, as demonstrated by the increased membrane translocation of RhoA and by phosphorylation of the ROCK substrate myosin phosphatase target subunit 1 (MYPT-1). In agreement with these data, C3 exoenzyme, a selective RhoA inhibitor, inhibits IL-8-induced invasion of BPH cells. The VDR agonist elocalcitol significantly inhibits IL-8 production by BPH cells stimulated with inflammatory cytokines, and IL-8-induced proliferation of BPH cells. In addition, elocalcitol inhibits IL-8-induced membrane translocation of RhoA and MYPT-1 phosphorylation in BPH cells, and inhibits dose-dependently their IL-8-dependent invasion. The inhibition induced by elocalcitol of IL-8 production by BPH cells is accompanied by decreased COX-2 expression and PGE2 production and by arrest of NF-κB p65 nuclear translocation, associated with inhibition of the RhoA/ROCK pathway. CONCLUSIONS. These data provide a mechanistic explanation for the anti-proliferative and anti-inflammatory properties of elocalcitol in BPH cells.

AB - BACKGROUND. Benign prostatic hyperplasia (BPH) is characterized by an important inflammatory component. Stimulation of human prostate stromal cells from BPH tissues with proinflammatory cytokines leads to secretion of IL-8, a chemokine involved in BPH pathogenesis. The vitamin D receptor (VDR) agonist elocalcitol can arrest prostate growth in BPH patients, but its mechanism of action in this pathology is still incompletely understood. METHODS. IL-8 levels were measured by real-time RT-PCR and ELISA. NF-κB translocation and COX-2 expression were evaluated by confocal microscopy. RhoA and Rho-kinase (ROCK) gene expression and functional activity were studied by real-time RT-PCR, immuno-kinase assays, Western blot analysis, confocal microscopy, and cell invasion. RESULTS. Stimulation of BPH cells with IL-8 activates the calcium-sensitizing RhoA/ROCK pathway, as demonstrated by the increased membrane translocation of RhoA and by phosphorylation of the ROCK substrate myosin phosphatase target subunit 1 (MYPT-1). In agreement with these data, C3 exoenzyme, a selective RhoA inhibitor, inhibits IL-8-induced invasion of BPH cells. The VDR agonist elocalcitol significantly inhibits IL-8 production by BPH cells stimulated with inflammatory cytokines, and IL-8-induced proliferation of BPH cells. In addition, elocalcitol inhibits IL-8-induced membrane translocation of RhoA and MYPT-1 phosphorylation in BPH cells, and inhibits dose-dependently their IL-8-dependent invasion. The inhibition induced by elocalcitol of IL-8 production by BPH cells is accompanied by decreased COX-2 expression and PGE2 production and by arrest of NF-κB p65 nuclear translocation, associated with inhibition of the RhoA/ROCK pathway. CONCLUSIONS. These data provide a mechanistic explanation for the anti-proliferative and anti-inflammatory properties of elocalcitol in BPH cells.

KW - BPH cells

KW - Elocalcitol

KW - IL-8

KW - VDR agonist

UR - http://www.scopus.com/inward/record.url?scp=61949322951&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=61949322951&partnerID=8YFLogxK

U2 - 10.1002/pros.20896

DO - 10.1002/pros.20896

M3 - Article

C2 - 19107880

AN - SCOPUS:61949322951

VL - 69

SP - 480

EP - 493

JO - Prostate

JF - Prostate

SN - 0270-4137

IS - 5

ER -